Ophthalmology · Winter Haven, FL
NPI
1477524130
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
250 Avenue K SW, Ste 200
Winter Haven, FL, 33880
Phone (863) 297-5400
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.2M
23,633 services
Medicare patients, 2024
673
Average age 79
Drug cost, 2024
$487K
525 prescriptions
Company payments, 2025
$282
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Suk Moon was code J2777 (injection, faricimab-svoa, 0.1 mg), 15,000 times for 47 patients. In total Suk Moon billed 23,633 services in 37 codes, and Medicare paid $2.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 15,000 | 47 | $27.49 | $412K |
| J0178 Injection, aflibercept, 1 mg | Office | 1,798 | 202 | $659.92 | $1.2M |
| 67028 Intravitreal Injection | Office | 1,259 | 260 | $86.76 | $109K |
| 92134 Computerized Ophthalmic Imaging | Office | 1,179 | 342 | $27.41 | $32K |
| 99214 Office E&M - Established | Office | 881 | 573 | $84.42 | $74K |
| 92250 Angiography | Office | 731 | 565 | $24.30 | $18K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 632 | 23 | $265.13 | $168K |
| 99213 Office E&M - Established | Office | 544 | 241 | $58.13 | $32K |
| Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 465 | 29 | $196.53 | $91K |
| J7999 Compounded drug, not otherwise classified | Office | 120 | 43 | $61.99 | $7,439 |
| 99204 Office E&M - New | Office | 82 | 82 | $112.24 | $9,203 |
| 92235 Angiography | Office | 59 | 59 | $116.29 | $6,861 |
| 76512 Ultrasound - Nonspecific | Office | 30 | 23 | $32.64 | $979 |
By year: 2022 $2.0M for 10,219 services; 2023 $2.2M for 15,678 services; 2024 $2.2M for 23,633 services.
Medicare prescription drug claims, 2024
In 2024, the drug Suk Moon prescribed most often to Medicare patients was Prednisolone Acetate, with 152 prescriptions and refills. In total Suk Moon wrote 525 Medicare prescriptions that cost $487K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 152 | 189 | 86 | $6,805 |
| Eylea Aflibercept | 150 | 150 | 33 | $367K |
| Brimonidine Tartrate Generic | 45 | 97 | 16 | $332 |
| Cimerli Ranibizumab-Eqrn | 40 | 42 | Under 11 | $63K |
| Ketorolac Tromethamine Generic | 28 | 31 | 14 | $1,118 |
| Atropine Sulfate Generic | 26 | 34 | Under 11 | $1,151 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 25 | 66 | 13 | $317 |
| Vabysmo Faricimab-Svoa | 12 | 14 | Under 11 | $40K |
Brand drugs: 360 claims; generic drugs: 165 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Suk Moon $282 ($282 in general payments such as food, travel and fees) from 8 companies. The largest payer was Astellas Pharma US Inc with $117.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.